Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RITUXIMAB Cause Poor venous access? 299 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 299 reports of Poor venous access have been filed in association with RITUXIMAB (Rituxan). This represents 0.2% of all adverse event reports for RITUXIMAB.

299
Reports of Poor venous access with RITUXIMAB
0.2%
of all RITUXIMAB reports
8
Deaths
163
Hospitalizations

How Dangerous Is Poor venous access From RITUXIMAB?

Of the 299 reports, 8 (2.7%) resulted in death, 163 (54.5%) required hospitalization, and 10 (3.3%) were considered life-threatening.

Is Poor venous access Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 299 reports have been filed with the FAERS database.

What Other Side Effects Does RITUXIMAB Cause?

Off label use (39,751) Drug ineffective (32,186) Rheumatoid arthritis (19,850) Pain (16,675) Fatigue (15,602) Arthralgia (12,529) Rash (12,102) Drug intolerance (11,876) Infusion related reaction (11,871) Joint swelling (11,170)

What Other Drugs Cause Poor venous access?

VEDOLIZUMAB (1,043) INFLIXIMAB (917) INFLIXIMAB-DYYB (782) ECULIZUMAB (555) HUMAN IMMUNOGLOBULIN G (504) NATALIZUMAB (422) TOCILIZUMAB (287) METHOTREXATE (257) ABATACEPT (249) IDURSULFASE (175)

Which RITUXIMAB Alternatives Have Lower Poor venous access Risk?

RITUXIMAB vs RITUXIMAB-ABBS RITUXIMAB vs RITUXIMAB-ARRX RITUXIMAB vs RITUXIMAB-PVVR RITUXIMAB vs RIVAROXABAN RITUXIMAB vs RIVASTIGMINE

Related Pages

RITUXIMAB Full Profile All Poor venous access Reports All Drugs Causing Poor venous access RITUXIMAB Demographics